2 not yet recruiting, 1 completed, 1 unknown. 4 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Not yet recruiting 2, Completed 1, Unknown 1 |
| Phase 2 | 3 | Not yet recruiting 2, Unknown 1 |
Follow Diabetic Nephropathy Type 2: new trials by email Literature Review of Diabetic Nephropathy Type 2 trials Research Report on Diabetic Nephropathy Type 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vitamin D in Diabetic Neuropathy Vitamin D - Diabetic Nephropathy Type 2 | Phase 2 / Phase 3 | Not yet recruiting | Tanta University | 150 | 2026-10-01 | 2026-09-08 |
| Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic Nephropathy Acetylsalicylic Acid, Placebo - Diabetic Nephropathy Type 2 | Phase 2 / Phase 3 | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 355 | 2024-01-01 | 2023-10-05 |
| Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease Empagliflozin 25 MG, Enalapril Maleate 20 mg - Diabetic Nephropathy Type 2 | Phase 2 / Phase 3 | Unknown | Omar Tarek Elfarargi | 212 | 2023-03-01 | 2022-05-13 |
| Investigational and Comparative Study in the Management of Diabetic Nephropathy Tadalafil 20Mg Oral Tablet, Pentoxifylline 400 MG Oral Tablet - Diabetic Nephropathy Type 2 | Phase 3 | Completed | Tanta University | 90 | 2022-02-01 | 2024-05-14 |
Diabetes Complications (1) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Aspirin (1) · Enalapril (1) · Pentoxifylline (1) · Tablets (1) · Tadalafil (1) · Vitamin D (1) · empagliflozin (1)
Tanta University (2) · Omar Tarek Elfarargi (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1)
Egypt (1)
Omar T Elfarargi (1) · Wafaa S Hegab, Lecturer (1)